Daniel D. Waller

Natural history of relapsed myeloma, refractory to immunomodulatory drugs and proteasome inhibitors: a multicenter IMWG study

Shaji Kumar, Meletios Α. Dimopoulos, Efstathios Kastritis et al. · Leukemia · 2017 · 354 citations · Full text

Medicine, Immunology, Oncology +17

IL6 Promotes a STAT3-PRL3 Feedforward Loop via SHP2 Repression in Multiple Myeloma

Phyllis S.Y. Chong, Jianbiao Zhou, Julia S.L. Lim et al. · Cancer Research · 2019 · 80 citations · Full text

Medicine, Molecular Biology, Oncology +17

Unraveling the Prenylation–Cancer Paradox in Multiple Myeloma with Novel Geranylgeranyl Pyrophosphate Synthase (GGPPS) Inhibitors

Cyrus M. Lacbay, Daniel D. Waller, Jaeok Park et al. · Journal of Medicinal Chemistry · 2018 · 43 citations · Full text

Medicine, Oncology, Pharmacology +17

Nup53p is a Target of Two Mitotic Kinases, Cdk1p and Hrr25p

C. Patrick Lusk, Daniel D. Waller, Taras Makhnevych et al. · Traffic · 2007 · 40 citations · Full text

Life Sciences, Cell Biology, Molecular Biology +9

Rho5p Is Involved in Mediating the Osmotic Stress Response in <i>Saccharomyces cerevisiae</i> , and Its Activity Is Regulated via Msi1p and Npr1p by Phosphorylation and Ubiquitination

Robert B. Annan, Cunle Wu, Daniel D. Waller et al. · Eukaryotic Cell · 2008 · 31 citations · Full text

Life Sciences, Biochemistry, Molecular Biology +14